OrthoPediatrics Corp <KIDS.OQ> expected to post a loss of 30 cents a share - Earnings Preview
OrthoPediatrics Corp KIDS.OQ KIDS.O is expected to show a rise in quarterly revenue when it reports results on August 5 for the period ending June 30 2025
The Warsaw Indiana Indiana-based company is expected to report a 16.3% increase in revenue to $61.4 million from $52.8 million a year ago, according to the mean estimate from 7 analysts, based on LSEG data.
LSEG's mean analyst estimate for OrthoPediatrics Corp is for a loss of 30 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for OrthoPediatrics Corp is $37.00, about 44% above its last closing price of $20.72
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2025 | -0.45 | -0.45 | -0.46 | Missed | -2.1 |
Dec. 31 2025 | -0.33 | -0.31 | -0.69 | Missed | -120.2 |
Sep. 30 2024 | -0.22 | -0.24 | -0.34 | Missed | -41.1 |
Jun. 30 2024 | -0.26 | -0.27 | -0.26 | Beat | 5.1 |
Mar. 31 2024 | -0.41 | -0.40 | -0.34 | Beat | 15.9 |
Dec. 31 2023 | -0.28 | -0.28 | -0.29 | Missed | -3.4 |
Sep. 30 2023 | -0.23 | -0.23 | -0.20 | Beat | 10.3 |
Jun. 30 2023 | -0.20 | -0.22 | -0.13 | Beat | 39.9 |
This summary was machine generated August 1 at 20:01 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
